IYPCX
Price
$18.65
Change
-$0.14 (-0.75%)
Updated
Nov 13 closing price
VEIEX
Price
$28.92
Change
-$0.19 (-0.65%)
Updated
Nov 13 closing price
Ad is loading...

IYPCX vs VEIEX

Header iconIYPCX vs VEIEX Comparison
Open Charts IYPCX vs VEIEXBanner chart's image
Delaware Ivy Systematic Em Mkts Eq R
Price$18.65
Change-$0.14 (-0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$28.92
Change-$0.19 (-0.65%)
VolumeN/A
CapitalizationN/A
IYPCX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IYPCX vs. VEIEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYPCX is a StrongBuy and VEIEX is a Sell.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 113B vs. IYPCX (682M). VEIEX pays higher dividends than IYPCX: VEIEX (3.27) vs IYPCX (2.98). IYPCX was incepted earlier than VEIEX: IYPCX (12 years) vs VEIEX (31 years). IYPCX is a more actively managed with annual turnover of: 65.00 vs. VEIEX (5.00). IYPCX (0) and VEIEX (0) have matching initial minimum investment requirements. VEIEX annual gain was more profitable for investors over the last year : 18.77 vs. IYPCX (12.65). VEIEX return over 5 years is better than : 19.04 vs. IYPCX (2.28).
IYPCXVEIEXIYPCX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years31 years-
Gain YTD7.18412.26259%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets682M113B1%
Annual Yield % from dividends2.983.2791%
Returns for 1 year12.6518.7767%
Returns for 3 years-29.62-6.06489%
Returns for 5 years2.2819.0412%
Returns for 10 years28.2127.53102%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARA0.34N/A
N/A
Cara Therapeutics
PPL33.24-0.22
-0.66%
PPL Corp
PI194.54-4.76
-2.39%
Impinj
VNET3.48-0.10
-2.92%
VNET Group
CRBP17.94-0.65
-3.50%
Corbus Pharmaceuticals Holdings